CN Patent

CN103638028A — 嘧啶基氨基苯甲酰胺衍生物用于治疗全身性肥大细胞增多症的应用

Assigned to Novartis AG · Expires 2014-03-19 · 12y expired

What this patent protects

本发明涉及嘧啶基氨基苯甲酰胺衍生物用于制备治疗全身性肥大细胞增多症的药物的应用。

USPTO Abstract

本发明涉及嘧啶基氨基苯甲酰胺衍生物用于制备治疗全身性肥大细胞增多症的药物的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN103638028A
Jurisdiction
CN
Classification
—
Expires
2014-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.